114 related articles for article (PubMed ID: 38453615)
21. Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.
Jain R; Fu AC; Lim J; Wang C; Elder J; Sander SD; Tan H
J Manag Care Spec Pharm; 2018 Jan; 24(1):73-82. PubMed ID: 29290177
[TBL] [Abstract][Full Text] [Related]
22. Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United States.
Klink AJ; Chmielowski B; Feinberg B; Ahsan S; Nero D; Liu FX
J Manag Care Spec Pharm; 2019 Aug; 25(8):869-877. PubMed ID: 30945965
[TBL] [Abstract][Full Text] [Related]
23. Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis.
Gayle A; Schoof N; Alves M; Clarke D; Raabe C; Das P; Del Galdo F; Maher TM
Adv Ther; 2020 May; 37(5):2460-2476. PubMed ID: 32319038
[TBL] [Abstract][Full Text] [Related]
24. Healthcare resource utilization and cost among patients treated for early-stage triple-negative breast cancer.
Haiderali A; Rhodes WC; Gautam S; Huang M; Sieluk J; Skinner KE; Schwartzberg LS
Future Oncol; 2021 Oct; 17(29):3833-3841. PubMed ID: 34254533
[TBL] [Abstract][Full Text] [Related]
25. The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.
Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
Int J Chron Obstruct Pulmon Dis; 2019; 14():2409-2421. PubMed ID: 31749614
[TBL] [Abstract][Full Text] [Related]
26. Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA.
Bell CF; Priest J; Stott-Miller M; Kan H; Amelio J; Song X; Limone B; Noxon V; Costenbader KH
Lupus Sci Med; 2020; 7(1):e000357. PubMed ID: 32341790
[TBL] [Abstract][Full Text] [Related]
27. Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America & Europe.
Wolfson LJ; Castillo ME; Giglio N; Meszner Z; Molnar Z; Vazquez M; Wysocki J; Altland A; Kuter BJ; Rickard J; Rampakakis E
Hum Vaccin Immunother; 2019; 15(4):932-941. PubMed ID: 30681397
[TBL] [Abstract][Full Text] [Related]
28. Mortality and healthcare costs in Medicare beneficiaries with AL amyloidosis.
Quock TP; Chang E; Munday JS; D'Souza A; Gokhale S; Yan T
J Comp Eff Res; 2018 Nov; 7(11):1053-1062. PubMed ID: 30354284
[TBL] [Abstract][Full Text] [Related]
29. Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis.
Brookes MJ; Waller J; Cappelleri JC; Modesto I; DiBonaventura MD; Bohm N; Mokgokong R; Massey O; Wood R; Bargo D
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32938582
[TBL] [Abstract][Full Text] [Related]
30. Economic Burden of Illness in Adult Patients with Nocturia.
Dmochowski R; Brucker BM; Cole E; Kawahara S; Pulicharam R; Burk C; Tung A; Hale D
J Manag Care Spec Pharm; 2019 May; 25(5):593-604. PubMed ID: 30675816
[TBL] [Abstract][Full Text] [Related]
31. The direct and indirect costs of Dravet Syndrome.
Whittington MD; Knupp KG; Vanderveen G; Kim C; Gammaitoni A; Campbell JD
Epilepsy Behav; 2018 Mar; 80():109-113. PubMed ID: 29414539
[TBL] [Abstract][Full Text] [Related]
32. Assessing the burden of illness of chronic hepatitis C and impact of direct-acting antiviral use on healthcare costs in Medicaid.
Roebuck MC; Liberman JN
Am J Manag Care; 2019 Jun; 25(8 Suppl):S131-S139. PubMed ID: 31211526
[TBL] [Abstract][Full Text] [Related]
33. Direct cost and healthcare resource utilization of patients with migraine before treatment initiation with calcitonin gene-related peptide monoclonal antibodies by the number of prior preventive migraine medication classes.
Foster SA; Hoyt M; Ye W; Mason O; Ford JH
Curr Med Res Opin; 2022 May; 38(5):653-660. PubMed ID: 34761723
[TBL] [Abstract][Full Text] [Related]
34. Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis.
Strand V; Tundia N; Song Y; Macaulay D; Fuldeore M
J Manag Care Spec Pharm; 2018 Apr; 24(4):344-352. PubMed ID: 29578852
[TBL] [Abstract][Full Text] [Related]
35. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs.
Vekeman F; Magestro M; Karner P; Duh MS; Nichols T; van Waalwijk van Doorn-Khosrovani SB; Zonnenberg BA
J Med Econ; 2015; 18(12):1060-70. PubMed ID: 26201433
[TBL] [Abstract][Full Text] [Related]
36. Health Care Costs Associated with AKI.
Collister D; Pannu N; Ye F; James M; Hemmelgarn B; Chui B; Manns B; Klarenbach S;
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1733-1743. PubMed ID: 29051143
[TBL] [Abstract][Full Text] [Related]
37. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study.
Gustavsson A; Jonsson L; Rapp T; Reynish E; Ousset PJ; Andrieu S; Cantet C; Winblad B; Vellas B; Wimo A;
J Nutr Health Aging; 2010 Oct; 14(8):648-54. PubMed ID: 20922341
[TBL] [Abstract][Full Text] [Related]
38. Healthcare resource use and direct costs in severe aplastic anemia (SAA) patients before and after treatment with eltrombopag.
Cai B; Said Q; Li X; Li FY; Arcona S
J Med Econ; 2020 Mar; 23(3):243-251. PubMed ID: 31686551
[No Abstract] [Full Text] [Related]
39. Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes.
Pawaskar M; Iglay K; Witt EA; Engel SS; Rajpathak S
J Diabetes Complications; 2018 May; 32(5):451-457. PubMed ID: 29496365
[TBL] [Abstract][Full Text] [Related]
40. Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA.
Grivas P; DerSarkissian M; Shenolikar R; Laliberté F; Doleh Y; Duh MS
Future Oncol; 2019 Nov; 15(33):3809-3818. PubMed ID: 31596144
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
